Health News Releases

  • Today December 6
November 13, 11:35
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion
November 13, 10:55
Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that IDEAYA Biosciences, Inc.
Novotech and Biostar Pharma Partnership (Photo: Business Wire)
November 13, 08:58
Novotech and Biostar Establish Strategic Partnership Following Biostar’s HKEX Listing
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
November 12, 15:38
Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial
Merck, a leading science and technology company, today announced that the Phase III MANEUVER trial of pimicotinib, an investigational medicine being developed by Abbisko Therapeutics Co., Ltd., met it
November 12, 10:30
Huonslab reinforces HyDIFFUZE™ (Recombinant human hyaluronidase PH20) Intellectual Property by completing the US and EU Examination Request under PCT application.
Huonslab, Co. Ltd. (https://huonslab.com/layout/eng/home.php?go=main&) S. Korea, a subsidiary of Huons Global (https://huonsglobal.com/eng/home.php) (KOSDAQ:084110) and a global leader in recombinant
2024 Clinical Trials Arena Excellence Award Winner Presented to Novotech (Graphic: Business Wire)
November 12, 09:45
Novotech Recognized for Excellence in Business Expansion, Innovation, and Marketing at the 2024 Clinical Trials Arena Excellence Awards
Novotech, the global full-service clinical Contract Research Organization (CRO), has received multiple awards in the 2024 Clinical Trials Arena Excellence Awards, recognizing the achievements of our p
November 08, 16:10
Huons Speeds up Biopharmaceutical Development with Human-Derived Hyaluronidase and Expands Bio-Pharma Business by Acquiring Stake in PanGen
Huons Co., Ltd. (https://www.huons.com/eng/home.php?go=main)(KRX:243070) (Co-CEOs : Song Soo-young and Yoon Sang-bae) announced on November 5 that it has decided to acquire 2,647,378 shares of PanGen
SBC Medical Group Holdings Incorporated, a global owner, operator and provider of management service
November 08, 15:15
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”, or the “Company”, or “SBC”), a global owner, operator and provider of management services and products to cosmetic treatment cente
November 07, 10:15
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class Brut
Burjeel Holdings and Response Plus Medical launch $1mn Human Energy Health and Wellbeing Award (Phot
November 06, 15:10
Burjeel Holdings and Response Plus Medical launch $1mn Human Energy Health and Wellbeing Award
Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, and Response Plus Medical Services (RPM), the largest pre-hospital care and emergency medical services provider in t
November 05, 16:15
Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch and availability of Evercode™ Low Input Fixation kits (https://cts.busines
November 05, 15:10
Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company
Japan-based Global Specialty Pharmaceutical Company Kyowa Kirin Co., Ltd. (President and CEO: Masashi Miyamoto.) (TOKYO:4151) today announced that Masashi Miyamoto, Ph.D. will take the role of Chairma
November 04, 16:55
Celebrating 25 Years of Sculptra®: New Data and Recent Approval in China Cements Galderma’s Leadership in Regenerative Biostimulation
This month marks the 25th anniversary of the approval of Sculptra®, the first proven regenerative biostimulator with a unique poly-L-lactic acid (PLLA-SCA™) formulation.[1-5,10-16]Sculptra works with
November 03, 11:30
Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.medidata.com&esheet=54145051&newsitemid=20241031324962&lan=en-US&anchor=Medidata&index=1&md5=ae204c6a0f9fac4adb7ac338e882
(Photo: Business Wire)
November 03, 10:45
Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced its Neutrogena® brand is taking dermatological beauty to the next level by establ
November 03, 10:30
Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook
Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54142153&newsitemid=20241030235134&lan=en-US&anc
Rob Wojciechowski (Photo: Business Wire)
November 01, 16:10
ELIQUENT Life Sciences Announces: Rob Wojciechowski Joins Firm
ELIQUENT Life Sciences (ELIQUENT), a global regulatory consulting firm, today announced the appointment of Rob Wojciechowski as Managing Director of the Consulting Practice across Europe and the Asia-
November 01, 14:30
Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fmedidata.com&esheet=54142421&newsitemid=20241029570790&lan=en-US&anchor=Medidata&index=1&md5=0177f87e5f8ba1d95a947b55a8ead5ee
October 31, 09:13
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the US Food and Drug Administration (FDA) has accepted the Biologic License Application (BLA) for HLX14, an investigatio
October 30, 14:40
Parse Launches GigaLab to Scale Single Cell Sequencing to Billions of Cells Annually
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54143515&newsitemid=20241029413584&lan=en-US&anchor=Parse+Biosciences&index=1&md
October 30, 14:25
Naobios and Sumagen Successfully Optimize HIV Vaccine Candidate for Industrial Production
Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-based products, and Sumagen Canada Inc (Sumagen),
October 30, 10:45
World Stroke Organization Launches Global Coalition to Drive Policy Action on Stroke Care
On World Stroke Day, October 29, the World Stroke Organization (WSO) announces the launch of a global coalition aimed at accelerating policy action on stroke—now the second leading cause of death and
Boomi Partners with BASE life science to Accelerate Digital Transformation Across the Life Sciences
October 29, 15:25
Boomi Partners with BASE life science to Accelerate Digital Transformation Across the Life Sciences Industry
Boomi (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fboomi.com%2F&esheet=54141438&newsitemid=20241028722622&lan=en-US&anchor=Boomi&index=1&md5=0797880acb2d3b33005b1492eb4e78bc)™, t
October 29, 14:30
ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development
ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a leader in ultra-sensitive immunoassay technologies,
October 29, 13:50
BeiGene Mourns Death of Beloved Board Member Donald Glazer
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54142605&newsitemid=20241028061544&lan=en-US&anchor=BeiGene&index=1&md5=91bcb3b9baea32c9e4fd8e1120f
25 per page50 per page75 per page100 per page